Life Sciences

All Topics

Bill Introduced to Repeal R&D Expense Capitalization

Bill Introduced to Repeal R&D Expense Capitalization

AAFCPAs provides the following update to clients with expenditures incurred in connection with your trade or business which represent research and development costs in the experimental or laboratory sense. On Thursday, March 16th, Senators Maggie Hassan (D) of New Hampshire and Todd Young (R) of Indiana reintroduced a bill to repeal the required capitalization of […]